The X-linked hypophosphatemia market is estimated to be valued at USD 1.64 Bn in 2025 and is expected to reach USD 3.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032. https://livepositively.com/x-linked-hypophosphatemia-market-trends-and-strategic-outlook/